On Wednesday, Metropolis Healthcare granted 75,666 restrictive stock units (RSU) to eligible employees. The company’s nomination and remuneration committee made the announcement of approving the number of stock units offered to the employees.
The option of restrictive stock offered to employees, falls under the Metropolis Healthcare – restrictive stock unit plan, 2020. The company shared this information through an official exchange filing.
The nominal value of each share is Rs 2. Moreover, on Wednesday, the shares of Metropolis Healthcare were trading at Rs 1,367.95, showing a decline of 0.98 per cent.
Metropolis Healthcare is a multinational diagnostic and healthcare service provider headquartered in India. Established in 1980, the company offers a comprehensive range of pathology and radiology services.
With a network of state-of-the-art laboratories and diagnostic centres across India and other countries, Metropolis is known for its cutting-edge technology, accurate results, and a commitment to delivering high-quality healthcare solutions. The company serves millions of patients, healthcare providers, and corporate clients, catering to both individual and institutional needs.
In addition to diagnostic services, Metropolis also emphasises preventive healthcare and wellness programmes to promote healthier lives for its clientele. As a socially responsible organisation, Metropolis actively engages in community outreach and health awareness initiatives.
The company recently announced its June quarter earnings where it recorded a 13.8 percent decrease in consolidated profit, amounting to Rs 28.8 crore during the June quarter compared to the previous year. Moreover, the company’s earnings before interest, taxes, depreciation, and amortisation (EBITDA) margin also witnessed a decrease of approximately 2 percent compared to the same fiscal period in the previous year, falling from 24.5 percent.
Despite facing challenges due to the ongoing pandemic, Metropolis Healthcare continued to show resilience and maintained a steady performance in its core business operations.
